Analgesic efficacy of bradykinin B1 antagonists in a murine bone cancer pain model

Journal of Pain

Volumn 6, Issue 11, 2005, Pages 771-775

  Sevcik, Molly A ^a   Ghilardi, Joseph R ^a,b   Halvorson, Kyle G ^a   Lindsay, Theodore H ^a   Kubota, Kazufumi ^a   Mantyh, Patrick W ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Bradykinin; Murine; Nociception; Osteolysis; Pain; Sarcoma

Indexed keywords

B 6769; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; LF 22 0542; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CANCER; CANCER PAIN; CONTROLLED STUDY; DRUG EFFICACY; FEMUR; MALE; MOUSE; NONHUMAN; SARCOMA CELL;

ANIMALS; BONE NEOPLASMS; BRADYKININ; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; PAIN; RECEPTOR, BRADYKININ B1; SARCOMA;

EID: 27644540532     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2005.06.010     Document Type: Article

References (21)

1. S. Averill, S.B. McMahon, D.O. Clary, L.F. Reichardt, J.V. Priestley Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons Eur J Neurosci 7 1995 1484 1494
2. S. Braun, K. Pantel, P. Muller, W. Janni, F. Hepp, C.R.M. Kentenich, S. Gastroph, A. Wischnik, T. Dimpfl, G. Kindermann, G. Riethmuller, G. Schlimok Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 2000 525 533
3. R.E. Coleman Metastatic bone disease Clinical features, pathophysiology and treatment strategies Cancer Treat Rev 27 2001 165 176
4. R. Couture, M. Harrisson, R.M. Vianna, F. Cloutier Kinin receptors in pain and inflammation Eur J Pharmacol 429 2001 161 176
5. N. Coyle, J. Adelhardt, K.M. Foley, R.K. Portenoy Character of terminal illness in the advanced cancer patient Pain and other symptoms during the last four weeks of life J Pain Symptom Manage 5 1990 83 93
6. R. de Wit, F. van Dam, S. Loonstra, L. Zandbelt, A. van Buuren, K. van der Heijden, G. Leenhouts, H. Huijer Abu-Saad The Amsterdam Pain Management Index compared to eight frequently used outcome measures to evaluate the adequacy of pain treatment in cancer patients with chronic pain Pain 91 2001 339 349
7. J. Ferreira, A. Beirith, M.A. Mori, R.C. Araujo, M. Bader, J.B. Pesquero, J.B. Calixto Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice J Neurosci 25 2005 2405 2412
8. J. Ferreira, M.M. Campos, R. Araujo, M. Bader, J.B. Pesquero, J.B. Calixto The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level Neuropharmacology 43 2002 1188 1197
9. A. Fox, G. Wotherspoon, K. McNair, L. Hudson, S. Patel, C. Gentry, J. Winter Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia Pain 104 2003 683 691
10. P. Honore, N.M. Luger, M.A.C. Sabino, M.J. Schwei, S.D. Rogers, D.B. Mach, P. O'Keefe, M. Ramnaraine, D.R. Clohisy, P.W. Mantyh Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord Nat Med 6 2000 521 528
11. P. Honore, S.D. Rogers, M.J. Schwei, J.L. Salak-Johnson, N.M. Luger, M.A.C. Sabino, D.R. Clohisy, P.W. Mantyh Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons Neuroscience 98 2000 585 598
12. N.M. Luger, P. Honore, M.A.C. Sabino, M.J. Schwei, S.D. Rogers, D.B. Mach, D.R. Clohisy, P.W. Mantyh Osteoprotegerin diminishes advanced bone cancer pain Cancer Res 61 2001 4038 4047
13. D.B. Mach, S.D. Rogers, M.A.C. Sabino, N.M. Luger, M.J. Schwei, J.D. Pomonis, C.P. Keyser, D.R. Clohisy, D.J. Adams, P. O'Leary, P.W. Mantyh Origins of skeletal pain Sensory and sympathetic innervation of the mouse femur Neuroscience 113 2002 155 166
14. S. Mercadante, E. Arcuri Breakthrough pain in cancer patients Pathophysiology and treatment Cancer Treat Rev 24 1998 425 432
15. R. Payne Practice guidelines for cancer pain therapy Issues pertinent to the revision of national guidelines Oncology 12 1998 169 175
16. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat Rev Cancer 4 2004 71 78
17. D. Pruneau, F. Porreca, T.W. Vanderah, M. Barth, P. Dodey, J.L. Junien, V. Peyrou, J.M. Luccarini Nonpeptidic B1 receptor antagonists and their actions in pain 2004 Presented at the Peptide Receptors - From Gene to Therapy meeting, Montreal, Canada, July 31-August 4
18. M.A.C. Sabino, J.R. Ghilardi, J.L. Jongen, C.P. Keyser, N.M. Luger, D.B. Mach, C.M. Peters, S.D. Rogers, M.J. Schwei, C. de Felipe, P.W. Mantyh Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2 Cancer Res 62 2002 7343 7349
19. M.A. Sevcik, N.M. Luger, D.B. Mach, M.A.C. Sabino, C.M. Peters, J.R. Ghilardi, M.J. Schwei, H. Rohrich, C. De Felipe, M.A. Kuskowski, P.W. Mantyh Bone cancer pain The effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis Pain 111 2004 169 180
20. J.S. Taub, R. Guo, L.M. Leeb-Lundberg, J.F. Madden, Y. Daaka Bradykinin receptor subtype 1 expression and function in prostate cancer Cancer Res 63 2003 2037 2041
21. G.S. Walsh, K.M. Krol, M.D. Kawaja Absence of the p75 neurotrophin receptor alters the pattern of sympathosensory sprouting in the trigeminal ganglia of mice overexpressing nerve growth factor J Neurosci 19 1999 258 273